World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
23512
World Ranking
16178
National Ranking
530

Overview

Jean Donadieu is affiliated with the University of Paris-Saclay in France and has contributed significantly to research in medicine, particularly in areas overlapping biochemistry, genetics, and molecular biology. Their work spans multiple subfields including physiology, immunology, genetics, oncology, and molecular biology.

The main topics of Jean Donadieu's research include:

  • Histiocytic Disorders and Treatments
  • Blood disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Neutropenia and Cancer Infections
  • Parvovirus B19 Infection Studies
  • Chemokine receptors and signaling
  • Tumors and Oncological Cases

Jean Donadieu has published extensively in several academic journals. The most frequent publication venues are:

  • Blood
  • Pediatric Blood & Cancer
  • Blood Advances
  • British Journal of Haematology
  • HemaSphere

Some recent papers associated with Jean Donadieu's research activity include:

  • "ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition" (2021) in Blood
  • "Histiocytosis" (2021) in The Lancet
  • "Somatic genetic rescue of a germline ribosome assembly defect" (2021) in Nature Communications
  • "High frequency of clonal hematopoiesis in Erdheim-Chester disease" (2020) in Blood
  • "A joint international consensus statement for measuring quality of survival for patients with childhood cancer" (2023) in Nature Medicine

Collaboration has been a notable aspect of Jean Donadieu's career. Frequent co-authors include:

  • Christine Bellanné-Chantelot
  • Sébastien Héritier
  • Jean-François Emile
  • Blandine Beaupain
  • Julien Haroche

Their work collectively addresses complex aspects of histiocytic and blood disorders, as well as immunological conditions. The breadth of topics and collaboration networks highlight a multidisciplinary approach within medical research.

Best Publications

  • Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

    Jean-François Emile;Oussama Abla;Sylvie Fraitag;Annacarin Horne

  • B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

    Irene Puga;Montserrat Cols;Carolina M. Barra;Bing-Yang He

  • Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 Years

    Riccardo Haupt;Milen Minkov;Itziar Astigarraga;Eva Schäfer

  • High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

    Julien Haroche;Frédéric Charlotte;Laurent Arnaud;Andreas von Deimling

  • Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

    Julien Haroche;Fleur Cohen-Aubart;Jean-François Emile;Laurent Arnaud

  • The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

    Markus G. Seidel;Gerhard Kindle;Benjamin Gathmann;Isabella Quinti

  • Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

    Oussama Abla;Eric Jacobsen;Jennifer Picarsic;Zdenka Krenova

  • Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

    Eli L. Diamond;Benjamin H. Durham;Julien Haroche;Zhan Yao

  • Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

    Helmut Gadner;Milen Minkov;Nicole Grois;Ulrike Pötschger

  • Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients

    J.L. Stephan;V. Vlekova;F. Le Deist;S. Blanche

  • Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.

    Helmut Gadner;Nicole Grois;Ulrike Pötschger;Milen Minkov

  • Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

    Jean Donadieu;Thierry Leblanc;Brigitte Bader Meunier;Mohamed Barkaoui

  • Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.

    Aurélie Guyot-Goubin;Jean Donadieu;Mohamed Barkaoui;Stéphanie Bellec;Stéphanie Bellec

  • BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

    Sébastien Héritier;Jean-François Emile;Mohamed-Aziz Barkaoui;Caroline Thomas

  • Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease

    Julien Haroche;Fleur Cohen-Aubart;Jean-François Emile;Philippe Maksud

  • Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome

    Andrew J. Finch;Christine Hilcenko;Nicolas Basse;Lesley F. Drynan

  • Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis

    Baptiste N. Jaeger;Jean Donadieu;Céline Cognet;Claire Bernat;Claire Bernat;Claire Bernat

  • Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

    Christine Bellanné-Chantelot;Séverine Clauin;Thierry Leblanc;Bruno Cassinat

  • Congenital neutropenia: diagnosis, molecular bases and patient management

    Jean Donadieu;Odile Fenneteau;Blandine Beaupain;Nizar Mahlaoui

  • Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome.

    Yigal Dror;Jean Donadieu;Jutta Koglmeier;John Dodge

Frequent Co-Authors

Jean-François Emile
Jean-François Emile Versailles Saint-Quentin-en-Yvelines University
Frédéric Charlotte
Frédéric Charlotte Université Paris Cité
Zahir Amoura
Zahir Amoura Université Paris Cité
Alain Fischer
Alain Fischer Collège de France
Ahmed Idbaih
Ahmed Idbaih Sorbonne University
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Khê Hoang-Xuan
Khê Hoang-Xuan Université Paris Cité
Claire Fieschi
Claire Fieschi Université Paris Cité
Jan-Inge Henter
Jan-Inge Henter Karolinska University Hospital
Despina Moshous
Despina Moshous Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in medicine or healthcare but want flexible options beyond traditional MD or DO pathways, there are several online degree and certification routes available. Many students look for the easiest rn program to get into to quickly enter the workforce as a registered nurse. These programs often have fewer prerequisites and more accessible admission standards.

Others are drawn to positions in healthcare that focus on the administrative or technical side. For example, you can complete a degree from medical billing and coding schools that accept fafsa to start a career in medical records, insurance, or hospital administration while qualifying for financial aid.

If you're aiming to transition to nursing quickly, some absn programs that don't require teas offer accelerated nursing pathways without entrance exam stress. Alternatively, those interested in leadership roles can pursue a healthcare administration online degree, which opens doors to management and operations within healthcare organizations.

Each of these pathways offers unique benefits, faster entry points, and the flexibility of online study—helping you find a rewarding healthcare career that fits your goals and lifestyle.

Best Scientists Citing Jean Donadieu

Trending Scientists

Recently Published Articles